1. Academic Validation
  2. Radiosynthesis and Preclinical Evaluation of [68Ga]Ga-NOTA-PTP Profiling Plectin-1 Expression for Pancreatic Cancer Imaging

Radiosynthesis and Preclinical Evaluation of [68Ga]Ga-NOTA-PTP Profiling Plectin-1 Expression for Pancreatic Cancer Imaging

  • J Med Chem. 2026 Feb 12;69(3):2888-2899. doi: 10.1021/acs.jmedchem.5c02777.
Tingting Wang 1 Jingchao Li 2 Xiangping Chen 1 Xun Zhang 1 Dongsheng Zhang 1 Guangfa Wang 1 Jian Li 1 Yafei Zhang 1 Nian Liu 1 Xiao Chen 2 Xinhui Su 1
Affiliations

Affiliations

  • 1 Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China.
  • 2 Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing 400042, China.
Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains challenging to diagnose in its early stages. Capitalizing on the established overexpression of plectin-1 in PDAC, we developed a novel plectin-1-targeted positron emission tomography (PET) radiotracer, [68Ga]Ga-NOTA-PTP, for precise PDAC imaging. The NOTA-PTP conjugate was synthesized, characterized, and efficiently radiolabeled with 68Ga, achieving high radiochemical purity (>99%). The radiotracer displayed a strong binding affinity for plectin-1 (IC50 = 12.8 nM) and exhibited time-dependent accumulation in PDAC cells. In murine PDAC xenografts, PET imaging demonstrated the rapid and specific tumor uptake of [68Ga]Ga-NOTA-PTP, enabling the visualization of peritoneal metastases. Targeting specificity was further verified by both the significant reduction in tumor uptake upon preadministration of the unlabeled compound and the positive correlation between tracer accumulation and plectin-1 expression levels. Collectively, this work introduces the first plectin-1-targeted PET probe for specific and sensitive detection of PDAC and metastatic lesions through efficient plectin-1 engagement.

Figures
Products